ETCMX | RLBAX | ETCMX / RLBAX | |
Total Expense Ratio | 1.82 | 1.31 | 139% |
Annual Report Gross Expense Ratio | 1.89 | 1.31 | 144% |
Fund Existence | 10 years | 23 years | - |
Gain YTD | 6.464 | 13.947 | 46% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000 | 250 | 400% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 390M | 265B | 0% |
Annual Yield % from dividends | 1.06 | 1.10 | 97% |
Returns for 1 year | 2.69 | 7.84 | 34% |
Returns for 3 years | 32.11 | 47.39 | 68% |
Returns for 5 years | 24.20 | 37.69 | 64% |
Returns for 10 years | 73.17 | 67.66 | 108% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
HILVX | 23.22 | 0.14 | +0.61% |
Harbor Large Cap Value Inv | |||
JFNCX | 63.20 | 0.38 | +0.60% |
Janus Henderson Global Life Sciences C | |||
HADUX | 79.12 | 0.41 | +0.52% |
Horizon Equity Premium Income Advisor | |||
VDIPX | 30.50 | 0.03 | +0.10% |
Vanguard Developed Markets Index Ins Pls | |||
BUFSX | 14.88 | -0.04 | -0.27% |
Buffalo Small Cap Growth |